Screening blood glucose and blood pressure to prevent the risk of diabetes mellitus and hypertension
DOI:
https://doi.org/10.12928/jpm.v6i3.6689Keywords:
NCD, Vulnerable, Glucose screeningAbstract
During the covid 19 pandemic, Gamping Lor did not hold activities that risk causing crowds in order to avoid the transmission of covid 19, thus they didn’t do any activity. This condition will worsen public health conditions, which are vulnerable to exposure to NCD (Non-Communicable Diseases). In Indonesia, the number of people with DM (Diabetes mellitus) is estimated to increase by 2 times in 2030. The purpose of this service is to conduct screening for early detection of diabetes and hypertension in vulnerable communities of Gamping Lor. The method used is counseling and examination practice. The results of the activity there were 68 participants consisting of women 89.7% men 11.3%. with a picture of the following conditions; Hypertension, 35.3% prehypertension 27.3%, Normal 29.4%, Low 7.3%; hyperglycemia 15.2%, hypoglycemia, 4.5%, normal 83.3%; BMI status; Thin 11.11%, ideal,22.22%, Overweight, 20.6% Obesity level 1 , 34.9%; obesity grade 2; 11.11%. Participants with high hypertension conditions, but more normal sugar levels. Participants overweight to obesity are higher than the ideal and thin. Conclusion : Service I I went well according to plan. More participants were affected by pre and hypertension, but normoglucose, on the other hand, experienced the most overweight and obesity. So it is important to do a diet and fat burning program according to age.
References
I. Gobiņa et al., “Excess mortality associated with the COVID-19 pandemic in Latvia: a population-level analysis of all-cause and noncommunicable disease deaths in 2020,” BMC Public Health, vol. 22, no. 1, pp. 1–12, Dec. 2022, doi: 10.1186/S12889-022-13491-4/TABLES/2.
A. Hafeez et al., “The state of health in Pakistan and its provinces and territories, 1990-2019: a systematic analysis for the Global Burden of Disease Study 2019,” Lancet. Glob. Heal., vol. 11, no. 2, pp. e229–e243, Feb. 2023, doi: 10.1016/S2214-109X(22)00497-1.
K. Lisy, J. M. Campbell, C. Tufanaru, S. Moola, and C. Lockwood, “The prevalence of disability among people with cancer, cardiovascular disease, chronic respiratory disease and/or diabetes: a systematic review,” Int. J. Evid. Based. Healthc., vol. 16, no. 3, pp. 154–166, Sep. 2018, doi: 10.1097/XEB.0000000000000138.
D. Bourgeois, C. Inquimbert, L. Ottolenghi, and F. Carrouel, “Periodontal Pathogens as Risk Factors of Cardiovascular Diseases, Diabetes, Rheumatoid Arthritis, Cancer, and Chronic Obstructive Pulmonary Disease—Is There Cause for Consideration?,” Microorg. 2019, Vol. 7, Page 424, vol. 7, no. 10, p. 424, Oct. 2019, doi: 10.3390/MICROORGANISMS7100424.
D. E. Schraufnagel et al., “Air Pollution and Noncommunicable Diseases: A Review by the Forum of International Respiratory Societies’ Environmental Committee, Part 2: Air Pollution and Organ Systems,” Chest, vol. 155, no. 2, pp. 417–426, Feb. 2019, doi: 10.1016/J.CHEST.2018.10.041.
M. H. Priyanto, L. Legiawati, S. R. F. Saldi, E. Yunir, and E. Miranda, “Comparison of vitamin D levels in diabetes mellitus patients with and without diabetic foot ulcers: An analytical observational study in Jakarta, Indonesia,” Int. Wound J., pp. 1–9, Jan. 2023, doi: 10.1111/iwj.14066.
K. P. Puchner, R. Rodriguez-Fernandez, M. Oliver, and Z. Solomos, “Non-communicable diseases and tuberculosis: Anticipating the impending global storm,” Glob. Public Health, vol. 14, no. 9, pp. 1372–1381, Sep. 2019, doi: 10.1080/17441692.2019.1580760.
S. N. Bhupathiraju and F. B. Hu, “Epidemiology of Obesity and Diabetes and Their Cardiovascular Complications,” Circ. Res., vol. 118, no. 11, pp. 1723–1735, May 2016, doi: 10.1161/CIRCRESAHA.115.306825.
J. L. Brożek et al., “Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines—2016 revision,” J. Allergy Clin. Immunol., vol. 140, no. 4, pp. 950–958, Oct. 2017, doi: 10.1016/J.JACI.2017.03.050.
M. B. Davidson, “Historical review of the diagnosis of prediabetes/intermediate hyperglycemia: Case for the international criteria,” Diabetes Res. Clin. Pract., vol. 185, p. 109219, Mar. 2022, doi: 10.1016/J.DIABRES.2022.109219.
A. Bruno, “Pre-diabetes, Diabetes, Hyperglycemia, and Stroke: Bittersweet Therapeutic Opportunities,” Curr. Neurol. Neurosci. Rep., vol. 22, no. 11, pp. 781–787, Nov. 2022, doi: 10.1007/S11910-022-01236-0.
X. Y. Xu, A. Y. M. Leung, R. Smith, J. Y. H. Wong, P. H. Chau, and D. Y. T. Fong, “The relative risk of developing type 2 diabetes among individuals with prediabetes compared with individuals with normoglycaemia: Meta-analysis and meta-regression,” J. Adv. Nurs., vol. 76, no. 12, pp. 3329–3345, Dec. 2020, doi: 10.1111/JAN.14557.
R. Wagner et al., “Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes,” Nat. Med., vol. 27, no. 1, pp. 49–57, Jan. 2021, doi: 10.1038/s41591-020-1116-9.
J. W. J. Beulens et al., “Risk and management of pre-diabetes,” Eur. J. Prev. Cardiol., vol. 26, no. 2_suppl, pp. 47–54, Dec. 2019, doi: 10.1177/2047487319880041.
I. M. El-Kebbi, N. H. Bidikian, L. Hneiny, and M. P. Nasrallah, “Epidemiology of type 2 diabetes in the Middle East and North Africa: Challenges and call for action,” World J. Diabetes, vol. 12, no. 9, p. 1401, Sep. 2021, doi: 10.4239/WJD.V12.I9.1401.
M. Ibrahim et al., “Global status of diabetes prevention and prospects for action: A consensus statement,” Diabetes. Metab. Res. Rev., vol. 34, no. 6, p. e3021, Sep. 2018, doi: 10.1002/DMRR.3021.
A. Chaudhury et al., “Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management,” Front. Endocrinol. (Lausanne)., vol. 8, p. 224539, Jan. 2017, doi: 10.3389/FENDO.2017.00006/BIBTEX.
E. L. Johnson et al., “Standards of Medical Care in Diabetes—2019 Abridged for Primary Care Providers,” Clin. Diabetes, vol. 37, no. 1, p. 11, Jan. 2019, doi: 10.2337/CD18-0105.
M. Ortiz-Martínez, M. González-González, A. J. Martagón, V. Hlavinka, R. C. Willson, and M. Rito-Palomares, “Recent Developments in Biomarkers for Diagnosis and Screening of Type 2 Diabetes Mellitus,” Curr. Diab. Rep., vol. 22, no. 3, pp. 95–115, Mar. 2022, doi: 10.1007/S11892-022-01453-4/TABLES/4.
H. Ali, F. Bensaali, and F. Jaber, “Novel Approach to Non-Invasive Blood Glucose Monitoring Based on Transmittance and Refraction of Visible Laser Light,” IEEE Access, vol. 5, pp. 9163–9174, 2017, doi: 10.1109/ACCESS.2017.2707384.
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Yoni Astuti, Agus Suharto, Rifki Hulalata
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
Authors who publish with Jurnal Pemberdayaan: Publikasi Hasil Pengabdian Kepada Masyarakat agree to the following terms:
- Authors retain copyright and grant the journal the right of first publication with the work simultaneously licensed under a Creative Commons Attribution License (CC BY-SA 4.0) that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work.
